Business News • PR NewsWire • Important new analysis shows that Novartis' Entresto® is associated with higher relative health-related quality of life scores among HFrEF patients

Important new analysis shows that Novartis' Entresto® is associated with higher relative health-related quality of life scores among HFrEF patients

Important new analysis shows that Novartis' Entresto® is associated with higher relative health-related quality of life scores among HFrEF patients

EAST HANOVER, N.J., Sept. 19, 2016 /PRNewswire/ -- A new post-hoc analysis demonstrates that the decline in health-related quality of life (HRQL) scores associated with a heart failure (HF) hospitalization among patients taking Novartis' Entresto® (sacubitril/valsartan) was...

View More : http://www.prnewswire.com/news-releases/important-new-analysis-shows-that-novartis-entresto-is-associated-with-higher-re...

Releted News by prnewswire

Oracle Kicks off Oracle OpenWorld 2016 by Showcasing Industry-First Cloud Innovations

Le lac des cygnes déploie ses ailes dans l’océan Indien

Global Smartphone Market Estimated to Expand at a CAGR of 5.8% in Term of Volume Between 2016 and 2024 - PMR

Head and Neck Cancer Awareness Week Sees Patients, Caregivers and HCPs 'Uniting Voices'